Effect of Dapagliflozin on the Outcome of Radiofrequency Catheter Ablation in Patients with Type 2 Diabetes Mellitus and Atrial Fibrillation.

Fangyuan LuoLiping SunZhe WangYuekun ZhangJiaju LiYingwei ChenChunguang Qiu

Published in: Cardiovascular drugs and therapy (2022)

In patients with T2DM, treatment with dapagliflozin appears to be independently associated with a significant reduction in the risk of recurrent atrial arrhythmias after RFCA.

Keyphrases

catheter ablation
atrial fibrillation
left atrial
left atrial appendage
direct oral anticoagulants
heart failure
metabolic syndrome
skeletal muscle
left ventricular
percutaneous coronary intervention
glycemic control
adipose tissue
acute coronary syndrome